HAIFA ALRAWI: Open Payments
NPI 1699410605 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,071 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $222 · 2025 $1,071
Food & beverage: $1,071
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $236 |
| Lilly USA, LLC | 2 | $221 |
| Exact Sciences Corporation | 2 | $141 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $99 |
Products named: Wegovy, MOUNJARO, The Cologuard Plus Collection Kit, VOQUEZNA, JARDIANCE, XIFAXAN, Ozempic, Auvelity.
Industry payments across MI — which companies pay providers there.
